Oxeladin

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Oxeladin" – news · newspapers · books · scholar · JSTOR (July 2011) (Learn how and when to remove this message)

Oxeladin

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	R05DB09 (WHO)
Identifiers
IUPAC name 2-(2-diethylaminoethoxy)ethyl 2-ethyl-2-phenyl-butanoate
CAS Number	468-61-1 N
PubChem CID	4619
DrugBank	DB04822 Y
ChemSpider	4458 Y
UNII	SNC1080T5Y
KEGG	D08310 Y
ChEMBL	ChEMBL1500276 N
CompTox Dashboard (EPA)	DTXSID0048343
ECHA InfoCard	100.006.740
Chemical and physical data
Formula	C20H33NO3
Molar mass	335.488 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(OCCOCCN(CC)CC)C(c1ccccc1)(CC)CC
InChI InChI=1S/C20H33NO3/c1-5-20(6-2,18-12-10-9-11-13-18)19(22)24-17-16-23-15-14-21(7-3)8-4/h9-13H,5-8,14-17H2,1-4H3 Y Key:IQADUMSPOQKAAO-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Oxeladin is a cough suppressant.^[1] It is a highly potent and effective drug used to treat all types of cough of various etiologies. It is not related to opium or its derivatives, so treatment with oxeladin is free of risk of dependence or addiction. Oxeladin has none of the side effects (such as hypnosis, respiratory depression, tolerance, constipation and analgesia) which are present when common antitussives, such as codeine and its derivatives, are used. It may be used at every age, as well as in patients with heart disease, since it has a high level of safety and a great selectivity to act on the bulbar centre of cough.